In cardiac hypertrophy and the fibrotic response, the JAK2–STAT3 signaling pathway activates TGFB, COL1A1, and MYH7 transcription, contributing to cardiac remodeling and dysfunction53. Here, JAK2 is linked to cardiac hypertrophy.